Publication:
EP-1331: Diabetes and metformin influence survival in glioblastoma patients

dc.bibliographiccitation.firstpageS719
dc.bibliographiccitation.journalRadiotherapy and Oncology
dc.bibliographiccitation.volume115
dc.contributor.authorAdeberg, S.
dc.contributor.authorKehle, D.
dc.contributor.authorMohr, A.
dc.contributor.authorRieken, S.
dc.contributor.authorBostel, T.
dc.contributor.authorKoelsche, C.
dc.contributor.authorDiehl, C.
dc.contributor.authorDebus, J.
dc.date.accessioned2020-07-10T10:06:49Z
dc.date.available2020-07-10T10:06:49Z
dc.date.issued2015
dc.identifier.doi10.1016/S0167-8140(15)41323-4
dc.identifier.urihttps://resolver.sub.uni-goettingen.de/purl?gro-2/67039
dc.relation.issn0167-8140
dc.titleEP-1331: Diabetes and metformin influence survival in glioblastoma patients
dc.typejournal_article
dc.type.internalPublicationno
dspace.entity.typePublication

Files

Collections